证券记录 · 已归档季度
SNY
Sanofi · Healthcare · Drug Manufacturers - General
17被追踪持有人
0Δ持有人
119.31M持有股份
$5.63B报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -7.7% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 517.20K | $21.14M | n/a | n/a |
| Q2 2026 | 111 | +6 | 144.61M | $6.22B | +8 | −2 |
| Q1 2026 | 107 | -7 | 161.36M | $7.80B | +3 | −10 |
| Q4 2025 | 113 | 0 | 171.90M | $8.37B | n/a | n/a |
| Q3 2025 | 17 | 0 | 119.31M | $5.63B | +1 | −1 |
| Q2 2025 | 14 | -1 | 113.96M | $5.51B | n/a | −1 |
| Q1 2025 | 13 | -1 | 114.44M | $6.35B | +1 | −2 |
| Q4 2024 | 14 | 0 | 106.76M | $5.15B | n/a | n/a |
| Q3 2024 | 13 | 0 | 105.96M | $6.11B | +1 | −1 |
| Q2 2024 | 13 | n/a | 103.00M | $5.00B | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 68.93M | -3.9% | $3.25B | 1.8% | ▼ Trim | 6 | SEC ↗ |
| 2 | Fisher Asset Management ✦ | 12.58M | -4.2% | $593.72M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 3 | Morgan Stanley ✦ | 7.56M | n/a | $356.92M | 0.0% | n/c | 1 | SEC ↗ ×11 |
| 4 | T. Rowe Price ✦ | 5.87M | +6.3% | $277.23M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | BlackRock ✦ (被动) | 5.58M | +2.0% | $263.32M | 0.0% | ▲ Add | 2 | SEC ↗ ×9 |
| 6 | JPMorgan Chase ✦ | 5.31M | n/a | $250.67M | 0.0% | n/c | 1 | SEC ↗ ×22 |
| 7 | Wellington Management ✦ | 4.12M | -4.8% | $194.64M | 0.0% | ▼ Trim | 6 | SEC ↗ ×3 |
| 8 | Fidelity (FMR) ✦ | 2.97M | -17.5% | $140.36M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 9 | Goldman Sachs Group ✦ | 2.48M | n/a | $117.02M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 10 | Millennium Management ✦ | 1.43M | +1151.8% | $67.68M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 11 | PRIMECAP Management ✦ | 986.47K | -13.1% | $46.56M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 771.44K | +253.3% | $36.41M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 13 | Point72 Asset Management ✦ | 369.33K | 新增 | $17.43M | 0.0% | New | 1 | SEC ↗ |
| 14 | Geode Capital Management ✦ (被动) | 232.50K | -0.9% | $10.97M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 66.32K | -8.8% | $3.13M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 16 | State Street Global Advisors ✦ (被动) | 24.28K | 0.0% | $1.15M | 0.0% | Held | 4 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 17.51K | -3.6% | $826,283 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $17.43M | 0.0% |
已清仓
| Capital World Investors | $403.59M | 曾为 0.1% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 734 持有人, 204.41M 股份, $9.56B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据